The telecommunications satellite technology developer was valued at $1.4bn in a series C round backed by a Koch Industries subsidiary.

Credit Suisse Entrepreneur Capital co-led the insulin injection device developer’s latest round, participating alongside investors including Tandem Diabetes Care and Ypsomed.

Asahi Kasei Ventures took part in a $70m round for food waste technology provider Hazel Technologies while Zoll Medical Corporation bought portfolio company Respicardia.

SoftBank Vision Fund 2 led the physical training technology provider’s latest round, which took its total funding to $300m.

Cambrian Biopharma, LG, GlaxoSmithKline, Novo and Takeda all invested in the cell therapy developer to help it close its series C round.

The personalised dental care provider increased its overall funding to almost $200m in a GV-backed series C round.

Esri helped the satellite constellation operator take its total funding to $155m in a round that will fund the launch of more satellites.

The Youzu Interactive-backed credit rating services provider has collected $34.8m in a series C2 round led by CDB-CDC Capital.

The compliance and trust management platform developer has closed a $210m tranche for the round led by SoftBank Vision Fund 2 at a $5.3bn post-money valuation.

Mayo Clinic-backed Pendulum near doubled its total funding in a round that will support increased manufacturing of its lead probiotic product.